Gabapentin Capsule
Product Images NDC 67877-224

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67877-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 100mg Blister

FDA Label Image

Gabapentin-100mg-cap (Gabapentin 100mg Cap)

FDA Label Image

Gabapentin 300mg Blister

FDA Label Image

Gabapentin-300mg-cap (Gabapentin 300mg Cap)

FDA Label Image

Gabapentin 400mg Blister

FDA Label Image

Gabapentin-400mg-cap (Gabapentin 400mg Cap)

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

FDA Label Image

Gabapentin Fig1

The text describes a study with a 4-week dose titration period followed by a 4-week fixed dose period, where the pain score was measured. The study compares the effects of a placebo and Gabapentin at a dosage of 3600 mg/day. The text also includes a visual diagram, but it is not clear what it represents.*

FDA Label Image

Gabapentin Fig2

This appears to be a table displaying information related to a study on pain management with different doses of gabapentin and a placebo. The table shows mean pain scores at baseline and over the course of several weeks during the study. There are also columns for different dosage levels of gabapentin.*

FDA Label Image

Gabapentin Fig3

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.